TheEdgeResearch
Home / Stocks / DCHPF

Dechra Pharmaceuticals PLC (DCHPF)

OTC Healthcare Medical - Pharmaceuticals
$46.90 ▼ -0.21%
Market Cap
$5.34B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.51
52-Wk Range
30.0-47.4
CEO
Isidro A. Consunji
Country
GB
Currency
USD

Dechra Pharmaceuticals PLC operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Northwich, GB. The stock last traded at $46.90, down 0.21% on the session, giving a market capitalisation of $5.34B. On trailing twelve-month figures it carries a trailing P/E of -147.52, a net margin of -3.7%. Its beta of 0.51 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-147.52
Price / Sales
5.30
Price / Book
5.32
EV / EBITDA
51.48
Gross margin
56.0%
Operating margin
0.8%
Net margin
-3.7%
Return on equity
—
Debt / equity
0.67
Current ratio
2.85
Dividend yield
1.1%
Payout ratio
-185.3%
Company profile
Exchange
Other OTC
Employees
2,457
IPO date
2016-07-11
Headquarters
Northwich, GB
About Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC specializes in the entire lifecycle of veterinary products, from development and manufacturing to regulatory approval, marketing, and sales, primarily serving veterinarians. The company's operations are structured across three main divisions: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. Their extensive product portfolio addresses a diverse array of animal health needs. For companion animals such as dogs and cats, they offer treatments for endocrinological and dermatological conditions, pain relief and anesthesia, cardiovascular issues, and critical care, alongside specialized therapeutic pet nutrition to manage allergies, obesity, and heart or kidney diseases. For livestock including poultry, pigs, and cattle, Dechra provides water-soluble antibiotics, vaccines, and pain management solutions. Equine care products focus on addressing lameness and pain in horses and ponies. Beyond core pharmaceuticals, the company also distributes veterinary equipment, offers financial services, markets various pet diets, and surprisingly, is involved in the development, regulation, manufacture, and commercialization of crop protection products. Dechra's offerings reach the market through robust wholesaler and distributor networks. Incorporated in 1997 and based in Northwich, United Kingdom, the company maintains a significant international presence, operating across the UK, Germany, wider Europe, the United States, and other global territories.

Comparable companies

Dechra Pharmaceuticals PLC is most often compared with the following Healthcare names:

ABCZFANHGYASPHFCAKFYGALNFHNGZYINVVYIZQVFNHNKFSGIPF
More research on DCHPF
DCHPF technical analysis DCHPF TheEdge Score Compare against peers
Open full interactive analysis & DCF →